Weber Labs Increases Stake in Metalabs to 59.59% via Third-Party Allotment, Raising Dilution Concerns for Existing Shareholders
Weber Labs increased its stake in Metalabs from 55.69% to 59.59% by acquiring 2.4 million new shares through a third-party allotment.
The issuance price of 2,500 KRW per share is a premium to the current price of 1,059 KRW, but total shares outstanding rose by 9.64% to 27,304,689, diluting existing shareholders.
The 6 billion KRW acquisition was funded by related party Meta Pharm using its own cash, resulting in Meta Pharm holding an 8.79% stake post-issuance.
Weber Labs and related party Lee Jong-woo have pledged 12,258,963 shares representing 49.22% of total shares as collateral to HEALTHVITA ASIA LTD.
[AI Summary]Weber Labs' stake increase reinforces control but the third-party allotment dilutes existing shareholders. While the issuance price is at a premium, the high proportion of pledged shares poses additional downside risk.